Isabel María Vegas-Aguilar

Isabel María Vegas-Aguilar

Auto-generated profile, based on publicly available information

Isabel María Vegas-Aguilar

Department of Endocrinology and Nutrition, Virgen de la Victoria University Hospital, 29010 Málaga, Spain

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 March 2023 in Endocrinología, Diabetes y Nutrición (English Ed.)
Verified
Journal Article
Closed access
JAJosé Manuel García Almeida
José Manuel García Almeida
CGCristina García-García
Cristina García-García
IVIsabel María Vegas-Aguilar
Isabel María Vegas-Aguilar
MBMaría D. Ballesteros-Pomar
María D. Ballesteros-Pomar
ICIsabel Cornejo-Pareja
Isabel Cornejo-Pareja
FTFrancisco Tinahones
Francisco Tinahones

13 July 2022 in Endocrinología, Diabetes y Nutrición
Verified
Journal Article
Closed access
JAJosé Manuel García Almeida
José Manuel García Almeida
CGCristina García-García
Cristina García-García
IVIsabel María Vegas-Aguilar
Isabel María Vegas-Aguilar
MBMaría D. Ballesteros-Pomar
María D. Ballesteros-Pomar
ICIsabel Cornejo-Pareja
Isabel Cornejo-Pareja
FTFrancisco Tinahones
Francisco Tinahones

19 January 2023 in Nutrients
Verified
Journal Article
Open access
PDF file
CGCristina García-García
Cristina García-García
IVIsabel María Vegas-Aguilar
Isabel María Vegas-Aguilar
RRRosalía Rioja-Vázquez
Rosalía Rioja-Vázquez
ICIsabel Cornejo-Pareja
Isabel Cornejo-Pareja
FTFrancisco Tinahones
Francisco Tinahones
JAJosé Manuel García Almeida
José Manuel García Almeida
Background: Cancer-related malnutrition is still unrecognized and undertreated in clinical practice. The morphofunctional assessment of disease-related malnutrition (DRM) is a new approach that focuses on evaluating changes in body composition and function. The aim of this study is to evaluate the prognostic value of classic and emerging assessment of malnutrition at 12-months survival in cancer patients. Methods. We conducted a prospective study on cancer outpatients. Bioelectrical impedance with phase angle (PhA), nutritional ultrasound by rectus femoris cross-sectional area (RFCSA), hand grip strength, and “Timed Up and Go Test” (TUG) were evaluated as predictors of mortality. Results. Fifty-seven patients were included. The non-survivors had lower PhA values than the survivors (4.7° vs. 5.4°; p < 0.001), and we had the same results with RFCSA 2.98 cm2/m2 vs. 4.27 cm2/m2 (p = 0.03). Cut-off points were identified using the ROC (receiver operating characteristic) curves for PhA (≤5.6° cancer patients, ≤5.9° men, ≤5.3° women), RFCSA (≤4.47 cm2/m2 cancer patients, ≤4.47° men, ≤2.73° women) and rectus femoris-Y-axis (RF-Y-axis; ≤1.3 cm cancer patients, ≤1.06 men, ≤1 women). In multivariate logistic regression analysis, we found that high PhA was significantly associated with a lower mortality hazard ratio (HR: 0.42 95% CI: 0.21–0.84, p = 0.014). Likewise, high RFCSA was associated with a decrease in mortality risk in the crude model (HR: 0.61 95% CI: 0.39–0.96, p = 0.031). This trend was also maintained in the adjusted models by the confounding variables. Conclusions. Low PhA and RFCSA values are significant independent predictors of mortality in cancer patients. These cut-off points are clinical data that can be used for nutritional assessment and the prediction of clinical outcomes.

3 December 2021 in Nutrients
Verified
Journal Article
Open access
PDF file
ICIsabel Cornejo-Pareja
Isabel Cornejo-Pareja
MRMaria Ramirez
Maria Ramirez
MRMaria Camprubi Robles
Maria Camprubi Robles
RRRicardo Rueda
Ricardo Rueda
IVIsabel Maria Vegas-Aguilar
Isabel Maria Vegas-Aguilar
JAJosé Manuel García Almeida
José Manuel García Almeida
This is a retrospective study of data from clinical practice to observe the effect of a high-calorie, high-protein oral nutritional supplement (ONS) with β-hydroxy-β-methylbutyrate (HMB) on nutritional status, body weight, and muscle-related parameters in 283 adult patients with or at risk of malnutrition under standard of care, 63% being cancer patients. They were recommended to increase physical activity and energy and protein intake from regular diet plus two servings per day of a specialized ONS enriched with HMB or standard ONS for up to 6 months. Dietary records, adherence and tolerance to ONS, nutritional status, body composition, handgrip strength, and blood analysis at the beginning and the end of the intervention were recorded. This program improved nutritional status from 100% malnourished or at risk of malnutrition at baseline to 80% well-nourished at final visit. It also increased body weight by 3.6–3.8 kg, fat-free mass by 0.9 to 1.3 kg, and handgrip strength by 4.7 to 6.2 kg. In a subgroup of patients (n = 43), phase angle (PhA), and body cell mass (BCM) increased only in the patients receiving the ONS enriched with HMB (0.95 (0.13) vs. −0.36 (0.4), and 2.98 (0.5) vs. −0.6 (1.5) kg, mean difference (SE) from baseline for PhA and BCM, respectively), suggesting the potential efficacy of this supplement on muscle health.

17 April 2024 in European Journal of Clinical Investigation
Verified
Journal Article
Open access
MAMaite Aguas‐Ayesa
Maite Aguas‐Ayesa
PYPATRICIA YÁRNOZ
PATRICIA YÁRNOZ
CPCarolina M. Perdomo
Carolina M. Perdomo
LOLaura Olazarán
Laura Olazarán
IVIsabel M. Vegas‐Aguilar
Isabel M. Vegas‐Aguilar
GFGema Frühbeck
Gema Frühbeck
Adolphe Quételet, a 19th‐century Belgian sociologist and statistician, pioneered the incorporation of statistics into social sciences. He initiated the development of anthropometry since he was interested in identifying the proportions of the ‘ideal man’. He devised a ratio between weight and height, originally termed the Quételet Index , and today widely known and used as the body mass index or BMI. In 1835, he demonstrated that a normal curve accommodates the distribution of human traits articulating his reasoning on human variance around the average. Quételet's long‐lasting legacy of the establishment of a simple measure to classify people's weight relative to an ideal for their height endures today with minor variations having dramatically influenced public health agendas. While being very useful, the limitations of the BMI are well known. Thus, revisiting the beyond BMI paradigm is a necessity in the era of precision medicine with morphofunctional assessment representing the way forward via incorporation of body composition and functionality appraisal. While healthcare systems were originally designed to address acute illnesses, today's demands require a radical rethinking together with an original reappraisal of our diagnosis and treatment approaches from a multidimensional perspective. Embracing new methodologies is the way forward to advance the field, gain a closer look at the underlying pathophysiology of excess weight, keep the spotlight on improving diagnostic performance and demonstrate its clinical validity. In order to provide every patient with the most accurate diagnosis together with the most appropriate management, a high degree of standardization and personalization is needed.

24 July 2023 in Reviews in Endocrine and Metabolic Disorders
Verified
Journal Article
Open access
PDF file
RJRocio Fernández Jiménez
Rocio Fernández Jiménez
RMRafael Martín-Masot
Rafael Martín-Masot
ICIsabel Cornejo-Pareja
Isabel Cornejo-Pareja
IVIsabel M Vegas-Aguilar
Isabel M Vegas-Aguilar
MHMarta Herrador-López
Marta Herrador-López
JAJosé Manuel García Almeida
José Manuel García Almeida
Phase angle (PhA) is a valuable tool for evaluating the nutritional and inflammatory status, which can accompany acute and severe disorders. PhA is a cellular health biomarker, whose value is particularly substantial due to the negative consequences of these situations in the pediatric population. Relevant literature was collected with the aim of comprehensively analysing the evidence on the association between an altered PhA can serve as a predictive-marker for mortality and poor-outcomes in at-risk-pediatric patients. Understanding this relationship could have significant implications for identifying high-risk individuals and implementing timely interventions. A systematic review with meta-analysis was conducted in the primary electronic databases from inception until January 2023. Overall, four studies with a total of 740 patients were eligible for our analysis. Evidence demonstrates that PhA is associated with nutritional status, reflecting undernutrition and changes in body composition related to illness. This review suggests that PhA can indeed be used as an indicator of nutritional status and a tool for predicting prognosis, including mortality and poor-outcomes, in hospitalized pediatric patients. A low PhA was associated with a significant mortality risk [RR:1.51;95%CI (1.22–1.88),p = 0.0002;I2 = 0%,(p = 0.99)] and an increased complications risk [OR:8.17;95%CI (2.44–27.4),p = 0.0007;I2 = 44%,(p = 0.18)]. These findings highlight the importance of taking a comprehensive approach to clinical nutrition, integrating multiple evaluation aspects to establish an accurate diagnosis and personalized therapeutic plans. While PhA emerges as a valuable tool for assessing the risk of malnutrition and as a prognostic-indicator for poor-outcomes in pediatric patients. Further future studies are needed to focus on investigating this relationship in larger and diverse population to strengthen the evidence base. Graphical Abstract